← Back to Clinical Trials
Recruiting NCT06935045

NCT06935045 Ethanol Consumption in the Heat

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06935045
Status Recruiting
Phase
Sponsor Lakehead University
Condition Alcohol Consumption
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2023-12-04
Primary Completion 2025-08

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Placebo BeverageAlcohol (Ethanol)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2023-12-04 with a primary completion date of 2025-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Climate change has significantly increased the earth's average surface temperature and heat waves have been predicted to increase in frequency, intensity and duration. Extreme heat events have increased the susceptibility to heat-related illnesses, such as heat exhaustion, heat stroke or death. Heat health action plans have been designed to advertise cooling behaviours to mitigate physiological strain. Heat health action plans suggest avoiding alcohol consumption during extreme heat as it may increase dehydration and impair behavioural or physiological temperature regulation and thermal perception. Regardless of these messages, alcohol sales continue to remain high during the summer months year after year, and 1/5 of adults identify alcohol as a hydration strategy during extreme heat events. A recent scoping review investigating the effects of alcohol and heat has demonstrated that acute alcohol consumption does not negatively influence thermoregulation, hydration, or hormone markers of fluid balance in the heat compared to a control fluid (https://doi.org/10.1186/s12940-024-01113-y). Further, alcohol consumption may elicit sex- and age-specific alterations in physiological and perceptual responses, neither of which have been explored. Therefore, this study aims to comprehensively evaluate how alcohol consumption systematically alters physiological responses and perceptions during conditions similar to those experienced indoors during extreme heat events in younger and older adults.

Eligibility Criteria

Inclusion Criteria: * Male or Female above the age of 19 * Able to provide informed consent Exclusion Criteria: * History of cardiovascular disease, cancer, type 1 or 2 diabetes, chronic obstructive pulmonary disorder, cystic fibrosis, or alcohol addiction or dependence * Been hospitalized due to COVID-19 * Pregnant/Breastfeeding * Scoring an eight or above on the Alcohol Use Disorders Identification Test (AUDIT)

Contact & Investigator

Central Contact

Nicholas Ravanelli, PhD

✉ nravanel@nus.edu.sg

📞 18073438010

Frequently Asked Questions

Who can join the NCT06935045 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Alcohol Consumption. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06935045 currently recruiting?

Yes, NCT06935045 is actively recruiting participants. Contact the research team at nravanel@nus.edu.sg for enrollment information.

Where is the NCT06935045 trial being conducted?

This trial is being conducted at Thunder Bay, Canada.

Who is sponsoring the NCT06935045 clinical trial?

NCT06935045 is sponsored by Lakehead University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology